Clinical trial
STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity…
NCT00277875 · Synvista Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00277875 |
|---|---|
| Title | STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH |
| Official title | The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Patients With Systolic Hypertension Before and After Receiving Oral Alagebrium for 8 Weeks. |
| Lead sponsor | Synvista Therapeutics, Inc, Industry |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | ALT-711 (alagebrium chloride) |
| Enrollment | 25 |
| Start date | Feb 1, 2004 |
| Primary completion | Dec 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Jan 18, 2006 |
| Last update posted | Aug 27, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: